4//SEC Filing
Smith Jason Drew 4
Accession 0001437749-25-023963
CIK 0001668243other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:03 PM ET
Size
6.1 KB
Accession
0001437749-25-023963
Insider Transaction Report
Form 4
Smith Jason Drew
General Counsel
Transactions
- Exercise/Conversion
Ordinary Shares
2025-07-28+16,500→ 49,014 total - Sale
Ordinary Shares
2025-07-28$19.14/sh−7,522$143,971→ 41,492 total
Footnotes (3)
- [F1]Represents the settlement of performance stock units granted on January 31, 2024 that vested upon the achievement of a corporate milestone event.
- [F2]Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F3]Represents shares sold to satisfy withholding tax obligations upon the settlement of performance stock units.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001821479
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:03 PM ET
- Size
- 6.1 KB